Skip to main content

Advertisement

SpringerLink
Log in

Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate?

  • CUTTING EDGE IN AUTOIMMUNITY
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Bullous skin diseases are characterized by genetic abnormalities related to structural epidermal proteins or organ-specific autoantibodies against the same proteins and are revealed by blister formation on skin or mucous membranes, with differences in blister depth, morphology, and topography. Both inherited and autoimmune forms of these disorders can be framed in the context of epidermolysis bullosa. Their clinical spectrum varies from early lethal to mild variants with normal life expectancy, and several distinct phenotypes differ for age of onset, extent, location and depth of skin and mucous lesions, or scarring severity. Recently, different inflammatory processes blended with autoimmune phenomena have been demonstrated in both inherited and acquired epidermolysis bullosa, revealing that this overlapping might cause substantial implications in terms of disease course and outcome. Although several associations between epidermolysis bullosa in its different variants and autoimmune diseases have been reported, it is not yet completely clear how it happens and why this association occurs in only some patients. Autoantibodies are the primary cause of the disease in acquired epidermolysis bullosa, whereas they can be produced as a secondary event due to genetically determined skin damage in inherited epidermolysis bullosa, contributing significantly to the worsening of the disease. The awareness of this overlap may help in identifying new therapeutic approaches with immunosuppressive drugs that could have a significant impact in terms of prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pearson RW. Studies on the pathogenesis of epidermolysis bullosa. J Invest Dermatol. 1962;39:551–75.

    Article  CAS  PubMed  Google Scholar 

  2. Fine JD. Inherited epidermolysis bullosa: past, present, and future. Ann N Y Acad Sci. 2010;1194:213–22.

    Article  CAS  PubMed  Google Scholar 

  3. Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol. 2012;30:70–7.

    Article  PubMed  Google Scholar 

  4. Sprecher E. Epidermolysis bullosa simplex. Dermatol Clin. 2010;28:23–32.

    Article  CAS  PubMed  Google Scholar 

  5. Bolling MC, Lemmink HH, Jansen GH, Jonkman MF. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol. 2011;164:637–44.

    CAS  PubMed  Google Scholar 

  6. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5:12.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Kelly-Mancuso G, Kopelan B, Azizkhan RG, Lucky AW. Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011. Pediatr Dermatol. 2014;31:159–62.

    Article  PubMed  Google Scholar 

  8. Bruckner-Tuderman L. Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol Clin. 2010;28:107–14.

    Article  CAS  PubMed  Google Scholar 

  9. Horn HM, Tidman MJ. The clinical spectrum of dystrophic epidermolysis bullosa. Br J Dermatol. 2002;146:267–74.

    Article  CAS  PubMed  Google Scholar 

  10. Mitsuhashi Y, Hashimoto I. Genetic abnormalities and clinical classification of epidermolysis bullosa. Arch Dermatol Res. 2003;295(Suppl 1):S29–33.

    CAS  PubMed  Google Scholar 

  11. Wiebe CB, Larjava HS. Abnormal deposition of type VII collagen in Kindler syndrome. Arch Dermatol Res. 1999;291:6–13.

    Article  CAS  PubMed  Google Scholar 

  12. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61:367–84.

    Article  PubMed  Google Scholar 

  13. Yuen WY, Duipmans JC, Molenbuur B, Herpertz I, Mandema JM, Jonkman MF. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. Br J Dermatol. 2012;167:374–82.

    Article  CAS  PubMed  Google Scholar 

  14. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009;61:387–402.

    Article  PubMed  Google Scholar 

  15. Feijoo JF, Bugallo J, Limeres J, Peñarrocha D, Peñarrocha M, Diz P. Inherited epidermolysis bullosa: an update and suggested dental care considerations. J Am Dent Assoc. 2011;142:1017–25.

    Article  PubMed  Google Scholar 

  16. Fine JD, Johnson LB, Weiner M, Stein A, Cash S, Deleoz J, et al. Pseudosyndactyly and musculoskeletal contractures in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry, 1986–2002. J Hand Surg Br. 2005;30:14–22.

    Article  PubMed  Google Scholar 

  17. Yuen WY, Jonkman MF. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol. 2011;65:780–9.

    Article  PubMed  Google Scholar 

  18. Garcia-Doval I, Davila-Seijo P, Langan SM. Updated systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa. Clin Exp Dermatol. 2013;38:92–4.

    Article  CAS  PubMed  Google Scholar 

  19. Falabella AF, Schachner LA, Valencia IC, Eaglstein WH. The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol. 1999;135:1219–22.

    Article  CAS  PubMed  Google Scholar 

  20. Shin KC, Park BY, Kim HK, Kim WS, Bae TH. The use of cultured allogenic keratinocyte grafting in a patient with epidermolysis bullosa simplex. Ann Dermatol. 2011;23:393–7.

    Article  Google Scholar 

  21. Gupta R, Woodley DT, Chen M. Epidermolysis bullosa acquisita. Clin Dermatol. 2012;30:60–9.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity. 2012;45:91–101.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Kasperkiewicz M, Hirose M, Recke A, Schmidt E, Zillikens D, Ludwig RG. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita. Brit J Dermatol. 2010;162:1064–70.

    Article  CAS  Google Scholar 

  24. Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Liévre N, Pascal F, Brette M-D, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C. Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol. 2011;131:2386–93.

    Article  CAS  PubMed  Google Scholar 

  25. Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: report of three cases and review of all published cases. Arch Dermatol. 1971;103:1–10.

    Article  PubMed  Google Scholar 

  26. Gammon WR, Briggaman RA, Woodley DT, Heald PW, Wheeler CE Jr. Epidermolysis bullosa acquisita: a pemphigoid- like disease. J Am Acad Dermatol. 1984;11:820–32.

    Article  CAS  PubMed  Google Scholar 

  27. Ludwig RJ. Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol. 2013;812029.

  28. Mutasim DF. Management of autoimmune bullous diseases: pharmacology and therapeutics. J Am Acad Dermatol. 2004;51:859–77.

    Article  PubMed  Google Scholar 

  29. Mutasim DF. Management of autoimmune bullous diseases: pharmacology and therapeutics. J Am Acad Dermatol. 2004;51:859–77.

    Article  PubMed  Google Scholar 

  30. Tampoia M, Bonamonte D, Filoni A, Garofalo L, Morgese MG, Brunetti L, Di Giorgio C, Annichiarico G. Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa. Orphanet J Rare Dis. 2013;8:132.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Freeman EB, Koglmeier J, Martinez AE, Mellerio JE, Haynes L, Sebire NJ, Lindley KJ, Shah N. Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol. 2008;158:1308–14.

    Article  CAS  PubMed  Google Scholar 

  32. Tampoia M, Garofalo L, Palmisano M, Bonamonte D, Filone A, et al. Anti-collagen VII autoantibodies and autoantibodies profile in patients with epidermolysis bullosa: an epiphenomenon or pathogenetic role? Autoimmunity Congress 2012 May 9–13, Granada, Spain.

  33. Annicchiarico G, Morgese MG, Brunetti L, Tampoia M, Garofalo L, Aceto G, et al. Improvement of renal function in epidermolysis bullosa patients after gluten free diet: two cases. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 4):138–41.

    PubMed  Google Scholar 

  34. Ishii N, Recke A, Mihai S, Hirose M, Hashimoto T, Zillikens D, Ludwig RJ. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita. J Pathol. 2011;224(2):234–44. doi:10.1002/path.2857.

    Article  CAS  PubMed  Google Scholar 

  35. Gubinelli E, Angelo C, Pacifico V. Am J Clin Dermatol. A case of dystrophic epidermolysis bullosa improved with etanercept for concomitant psoriatic arthritis. 2010;11(Suppl 1):53–4. doi:10.2165/1153427-S0-000000000-00000.

    Google Scholar 

  36. Málaga S, Fernández Toral J, Santos F, Riesgo I, Crespo M. Renal amyloidosis complicating a recessive epidermolysis bullosa in childhood. Helv Paediatr Acta. 1983;38:167–70.

    PubMed  Google Scholar 

  37. Mann JF, Zeier M, Zilow E, Schärer K, Anton-Lamprecht I, Waldherr R, et al. The spectrum of renal involvement in epidermolysis bullosa dystrophica hereditaria: report of two cases. Am J Kidney Dis. 1988;11:437–41.

    Article  CAS  PubMed  Google Scholar 

  38. Cuesta-Estellés G, Escobedo-Rumoroso JM, Garcés-López L, Pérez-García A. Epidermolysis bullosa and chronic renal failure. Nephrol Dial Transplant. 1998;1:2133–4.

    Article  Google Scholar 

  39. Mallipeddi R, Bleck O, Mellerio JE, Ashton GH, Eady RA, McGrath JA. Dilemmas in distinguishing between dominant and recessive forms of dystrophic epidermolysis bullosa. Br J Dermatol. 2003;149:810–8.

    Article  CAS  PubMed  Google Scholar 

  40. Kawasaki Y, Isome M, Takano K, Suyama K, Imaizumi T, Matsuura H, et al. IgA nephropathy in a patient with dominant dystrophic epidermolysis bullosa. Tohoku J Exp Med. 2008;214:297–301.

    Article  CAS  PubMed  Google Scholar 

  41. Massari S, Liso M, De Santis L, Mazzei F, Carlone A, Mauro S, Musca F, Bozzetti MP, Minelli M. Occurrence of nonceliac gluten sensitivity in patients with allergic disease. Int Arch Allergy Immunol. 2011;155:389–94.

    Article  CAS  PubMed  Google Scholar 

  42. Reddy H, Shipman AR, Wojnarowska F. Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature. Clin Exp Dermatol. 2013;38:225–9 (quiz 229–30).

    Article  CAS  PubMed  Google Scholar 

  43. Sheridan R, Robbins S, Elston D, Brown C, Quispe G. Resolution of epidermolysis bullosa aquisita with resection of intraabdominal Crohn’s disease. Mil Med. 1987;152:368–9.

    CAS  PubMed  Google Scholar 

  44. Labeille B, Gineston JL, Denoeux JP, Capron JP. Epidermolysis bullosa acquisita and Crohn’s disease. A case report with immunological and electron microscopic studies. Arch Intern Med. 1988;148:1457–9.

    Article  CAS  PubMed  Google Scholar 

  45. Schattenkirchner S, Lémann M, Prost C, Caux F, Guigui B, Cadot M, et al. Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn’s disease. Am J Gastroenterol. 1996;91:1657–9.

    CAS  PubMed  Google Scholar 

  46. Vicente EF, Hernández-Núñez A, Aspa J, Aragües M, García-Vicuña R. Crohn’s disease, relapsing polychondritis and epidermolysis bullosa acquisita: an immune-mediated inflammatory syndrome. Rheumatology (Oxford). 2008;47:380–1.

    Article  CAS  Google Scholar 

  47. Ormaechea-Pérez N, Tuneu-Valls A, Borja-Consigliere HA, Del Alcazar-Viladomiu E, Jaka-Moreno A. Peristomal epidermolysis bullosa acquisita in a patient with Crohn’s disease. Acta Derm Venereol. 2013; Epub Dec 5.

  48. Chan L, Woodley D. Epidermolysis bullosa acquisita in the elderly. J Geriatr Dermatol. 1995;4:47–52.

    Google Scholar 

  49. Park K, Nakano H, Sawamura D, Kabashima K, Miyachi Y. A case of dominant dystrophic epidermolysis bullosa with diabetes mellitus presenting as progressive recalcitrant blisters and erosions. Int Wound J. 2013; Epub Feb 24.

  50. Yoon J, Moon TK, Lee KH, Kim SC. Fatal vascular involvement in systemic lupus erythematosus following epidermolysis bullosa acquisita. Acta Derm Venereol. 1995;75:143–6.

    CAS  PubMed  Google Scholar 

  51. Duheille J, Leclere J, Nicolas JP, Weber M. Biermer’s anemia, chronic thyroiditis and polydysplasic bullous epidermolysis Immunologic and genetic considerations. Ann Med Interne (Paris). 1971;122:541–6.

    CAS  Google Scholar 

  52. Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin. 1993;11:535–47.

    Article  CAS  PubMed  Google Scholar 

  53. Woodley DT, Remington J, Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol. 2007;33(1–2):78–84.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via Commenda 9, 20122, Milan, Italy

    Susanna Esposito, Sophie Guez, Francesca Manzoni & Annalisa Bosco

  2. Institute of Pediatrics, Università Cattolica Sacro Cuore, Rome, Italy

    Donato Rigante

Authors
  1. Susanna Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie Guez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Manzoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annalisa Bosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Donato Rigante
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susanna Esposito.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esposito, S., Guez, S., Manzoni, F. et al. Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate?. Immunol Res 61, 63–69 (2015). https://doi.org/10.1007/s12026-014-8583-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-014-8583-3

Keywords

Search

Navigation